Alpha-2 adrenoceptor agonists and sepsis: improved survival?
Quintin
Luc
L
D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use*; D020927:Dexmedetomidine / Q000627:therapeutic use*; D005283:Fentanyl / Q000627:therapeutic use; D006801:Humans; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis
D058647:Adrenergic alpha-2 Receptor Agonists; D020927:Dexmedetomidine; D005283:Fentanyl